Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 2 |
2023 | 3 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer.
Front Oncol. 2023 Sep 22;13:1273478. doi: 10.3389/fonc.2023.1273478. eCollection 2023.
Front Oncol. 2023.
PMID: 37810988
Free PMC article.
Antitumor immune response is associated with favorable survival in GEP-NEN G3.
Rosery V, Reis H, Savvatakis K, Kowall B, Stuschke M, Paul A, Dechêne A, Yang J, Zhao B, Borgers A, Kasper S, Schuler M, Cheung PF, Siveke JT.
Rosery V, et al.
Endocr Relat Cancer. 2021 Sep 2;28(10):683-693. doi: 10.1530/ERC-21-0223.
Endocr Relat Cancer. 2021.
PMID: 34472429
Item in Clipboard
Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols.
Roehrle J, Kasper S, Treckmann JW, Markus P, Schumacher B, Albers D, Wendling J, Ting S, Mende B, Maßmann M, Markus M, Virchow I, Rosery V, Laue K, Zaun G, Kostbade K, Pogorzelski M, Reissig TM, Liffers ST, Schmid K, Schildhaus HU, Schuler M, Siveke JT, Wiesweg M.
Roehrle J, et al. Among authors: rosery v.
Oncol Res Treat. 2023;46(4):140-150. doi: 10.1159/000529452. Epub 2023 Jan 31.
Oncol Res Treat. 2023.
PMID: 36720216
Item in Clipboard
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.
Rosery V, Mika S, Schmid KW, Reis H, Stuschke M, Treckmann J, Markus P, Schumacher B, Albers D, Mende B, Lahner H, Wiesweg M, Schuler M, Siveke JT, Kasper S.
Rosery V, et al.
J Cancer Res Clin Oncol. 2023 Jul;149(8):4315-4325. doi: 10.1007/s00432-022-04314-5. Epub 2022 Sep 8.
J Cancer Res Clin Oncol. 2023.
PMID: 36071236
Free PMC article.
Item in Clipboard
Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis.
Stratmann JA, Timalsina R, Atmaca A, Rosery V, Frost N, Alt J, Waller CF, Reinmuth N, Rohde G, Saalfeld FC, von Rose AB, Acker F, Aspacher L, Möller M, Sebastian M.
Stratmann JA, et al. Among authors: rosery v.
Ther Adv Med Oncol. 2022 Jun 4;14:17588359221097191. doi: 10.1177/17588359221097191. eCollection 2022.
Ther Adv Med Oncol. 2022.
PMID: 35677321
Free PMC article.
Item in Clipboard
Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy.
Mülling N, Rosery V, Reinhardt HC, Hanoun M.
Mülling N, et al. Among authors: rosery v.
Eur J Med Res. 2021 Jun 29;26(1):63. doi: 10.1186/s40001-021-00533-7.
Eur J Med Res. 2021.
PMID: 34187575
Free PMC article.
Item in Clipboard
Cite
Cite